Instem to Host SEND Implementation Panel Session at Society of Toxicology Annual Meeting
Panelists to Discuss Key Factors in Becoming SEND-Ready
CONSHOHOCKEN, PA – March 18, 2015 - - Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce it will be moderating a panel discussion on the preparation and implementation of CDISC’s Standard for the Exchange of Nonclinical Data (SEND) at the Society of Toxicology Annual Meeting in San Diego, March 23rd. Joining the panel are contacts from Allergan, Bristol-Myers Squibb and MPI Research.
The session, “Practical SEND Planning and Implementation: Key Learnings from a Dedicated Community of Experience and Expertise” will review the experiences of twenty-one sponsors and CROs across eleven countries that have completed or are implementing new processes for SEND. The panel discussion will allow attendees to hear from both CRO and sponsor organizations that are implementing solutions for SEND compliance. The presentation will also include a review of Final Guidance implications, project planning, workflow considerations, Sponsor/CRO relationships, 21 CFR Part 11 compliance and strategies for leveraging the data.
“Since the FDA’s issuance of Final Guidance at the end of last year, we have seen a marked increase in the number of organizations who are turning to Instem to help them become SEND enabled,” comments Mike Harwood, Senior VP at Instem. “This session will provide further opportunity for organizations to understand the practical implications of SEND and will assist them in any stage of their planning”.
“Practical SEND Planning and Implementation: Key Learnings from a Dedicated Community of Experience and Expertise” will take place Monday, March 23 at 4:45PM PDT in room 24C of the San Diego Convention Center. Complimentary appetizers and drinks will be provided.
Instem is exhibiting at the Society’s ToxExpo, the largest exhibition dedicated to toxicology and the biomedical sciences, taking place March 23rd – 25th at the San Diego Convention Center. Instem’s product and industry experts will be on-hand at booth #1127 to discuss and demo the latest features of Provantis 9 as well as its submit-SEND solutions.
The Society of Toxicology Annual Meeting and ToxExpo will welcome over 6,500 attendees from more than 50 countries around the world.
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Press Contacts:
Instem
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990
Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600
